(Q44393974)

English

Decreasing levels of tumour necrosis factor alpha and interleukin 6 during lowering of body mass index with orlistat or placebo in obese subjects with cardiovascular risk factors

scientific article published in May 2003

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Decreasing levels of tumour necrosis factor alpha and interleukin 6 during lowering of body mass index with orlistat or placebo in obese subjects with cardiovascular risk factors (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

circulatory system

1 reference

based on heuristic

inferred from title

author name string

Samuelsson L

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Gottsäter A

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Lindgärde F

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

publication date

1 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

195-201

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Effects of sibutramine on body weight and serum lipids: a double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00264.X

21 January 2018

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00264.X

21 January 2018

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00264.X

21 January 2018

Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00264.X

21 January 2018

Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00264.X

21 January 2018

In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00264.X

21 January 2018

In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00264.X

21 January 2018

Isoprostanes: potential markers of oxidant stress in atherothrombotic disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00264.X

21 January 2018

F2-isoprostane evidence of oxidant stress in the insulin resistant, obese Zucker rat: effects of vitamin E.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00264.X

21 January 2018

Oxidative stress in a rat model of obesity-induced hypertension.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00264.X

21 January 2018

Long-term pharmacotherapy of obesity 2000: a review of efficacy and safety

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00264.X

21 January 2018

The effect of orlistat on body weight and coronary heart disease risk profile in obese patients: the Swedish Multimorbidity Study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00264.X

21 January 2018

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00264.X

21 January 2018

Elevated Levels of Interleukin 6 Are Reduced in Serum and Subcutaneous Adipose Tissue of Obese Women after Weight Loss

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00264.X

21 January 2018

Elevated C-reactive protein levels in overweight and obese adults

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00264.X

21 January 2018

Identifiers

10.1046/J.1463-1326.2003.00264.X

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44393974&oldid=2020950441"